This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To compare causes of in-hospital death after aneurysmal subarachnoid hemorrhage (aSAH) in 2 time periods within the same institution.
Methods: From a prospectively collected institutional database, we retrieved data on 844 consecutive patients with aSAH admitted ≤3 days after ictus in 1999–2002 and 2009–2012. We assessed case-fatality <90 days and causes of in-hospital death and used Poisson regression analyses to calculate adjusted risk ratios (aRR) with corresponding 95% confidence intervals (CI) for change in individual causes of death, with the first time period as the reference group.
Results: Ninety-day case-fatality declined from 150/381 patients (39%) in 1999–2002 to 140/463 (30%) in 2009–2012 (aRR 0.74 [95% CI 0.62–0.88]). Compared with 1999–2002, the aRR for specific cause of in-hospital death in 2009–2012 was 1.06 (95% CI 0.72–1.56) for death from the initial bleeding, 0.47 (95% CI 0.31–0.71) for death from rebleeding, and 0.91 (95% CI 0.50–1.65) for death from delayed cerebral ischemia. Over time, the proportion of patients with in-hospital rebleeding declined from 90/381 (24%) to 78/463 (17%) (aRR 0.68 [95% CI 0.52–0.90]), median day of rebleeding from day 5 (IQR 1–10) to day 0 (IQR 0–1), and median day of aneurysm treatment from day 4 (IQR 2–13) to day 1 (IQR 1–2).
Conclusions: An important contributor to the reduction in in-hospital death is the reduction in death from rebleeding, which probably results from earlier aneurysm treatment. Our results stress the need for early occlusion of the aneurysm and the need for other strategies that improve outcome by reducing the risk of rebleeding.
GLOSSARY
- aRR=
- adjusted risk ratio;
- aSAH=
- aneurysmal subarachnoid hemorrhage;
- CI=
- confidence interval;
- DCI=
- delayed cerebral ischemia;
- IQR=
- interquartile range;
- PAASH=
- Prognosis on Admission of Aneurysmal Subarachnoid Hemorrhage;
- RR=
- risk ratio;
- SAH=
- subarachnoid hemorrhage
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received June 15, 2015.
- Accepted in final form August 31, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
